Allergy Therapeutics half-year loss narrows on lower expenses
(Alliance News) - Allergy Therapeutics PLC on Monday said talks are underway regarding further financing as it said reduced costs helped trim its half-year loss. Read More
Price | 6.875p on 09-05-2025 | at 18:20:07
---|---|
Change | -0.10p -1.39% |
Buy | 7.25p |
Sell | 6.50p |
Buy / Sell AGY Shares |
Last Trade: | Buy 90,000.00 at 7.10p |
Day's Volume: | 528,600 |
Last Close: | 7.10p |
Open: | 7.15p |
ISIN: | GB00B02LCQ05 |
Day's Range | 7.10p - 7.25p |
52wk Range: | 3.00p - 7.70p |
Market Capitalisation: | £338m |
VWAP: | 7.090144p |
Shares in Issue: | 4,766m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Allergy Thera. (AGY) Latest Trades |
||||
Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
---|---|---|---|---|
Buy* | 90,000 | 7.10p | Suspected BUY Trade |
16:35:03 - 09-May-25 |
Sell* | 1,600 | 6.50p | SI Trade |
16:35:03 - 09-May-25 |
Buy* | 40,000 | 7.10p | Ordinary |
14:00:44 - 09-May-25 |
Buy* | 80,000 | 7.25p | Suspected BUY Trade |
14:00:29 - 09-May-25 |
Sell* | 32,000 | 6.775p | Ordinary |
12:08:56 - 09-May-25 |
Unknown* | 100,000 | 6.866p | Ordinary |
11:35:08 - 09-May-25 |
Buy* | 25,000 | 7.25p | Ordinary |
11:09:49 - 09-May-25 |
Buy* | 50,000 | 7.15p | Suspected BUY Trade |
08:00:27 - 09-May-25 |
Buy* | 70,000 | 7.20p | Suspected BUY Trade |
16:35:09 - 08-May-25 |
Sell* | 381 | 6.866p | Ordinary |
14:12:16 - 08-May-25 |
Allergy Thera. (AGY) Regulatory News |
||
Date | Source | Headline |
---|---|---|
31st Mar 2025 7:00 am | RNS | Interim Results for six months ended 31 Dec 2024 |
27th Mar 2025 7:00 am | RNS | Advancement to final phase of PROTECT trial |
3rd Mar 2025 7:00 am | RNS | New Executive Long Term Incentive Awards |
27th Feb 2025 7:00 am | RNS-R | Presentations at 2025 AAAAI / WAO Joint Congress |
17th Feb 2025 7:00 am | RNS | Grass MATA MPL Phase III data published in Allergy |
14th Feb 2025 7:00 am | RNS | Grant of Options |
28th Jan 2025 7:00 am | RNS | Half Year Trading update |
22nd Jan 2025 7:00 am | RNS | PDMR Dealing and Total Voting Rights |
15th Jan 2025 7:00 am | RNS | Director/PDMR Shareholding |
19th Dec 2024 1:41 pm | RNS | Exercise of Options and Total Voting Rights |